Lone Pine Capital 13F: Adds $82M to Tenet Healthcare (THC) Stake
Lone Pine Capital increased its holdings in Tenet Healthcare Corporation by 26.4%, according to its latest SEC filing.
Reviewed by automated data checks against the source filing. How we make and check alerts
Lone Pine Capital added 471,391 shares to its stake in Tenet Healthcare Corporation ($THC), a 26.37% increase, according to a 13F filing with the SEC dated May 15, 2026. It reported 2,258,717 shares worth $394.51 million at the end of the quarter.
Since the filing, $THC is down 11.6% after 1 week, down 8.9% after 1 month and up 35.9% to date (from the $196.66 close on May 15, 2026).
Find the original: Lone Pine Capital 13F filings on SEC EDGAR
Key Points
- Lone Pine Capital grew its stake in Tenet Healthcare Corporation (NYSE:THC) by 26.4%, adding 471,391 shares to finish the period with 2,258,717 shares worth about $394.5 million.
- The stock trades at $174.66, with a P/E ratio of 10.1 and a forward P/E of 12.4, sitting below its 50-day moving average of $250.51.
- Wall Street analysts maintain a strong buy consensus on the healthcare provider with a mean price target of $285.57 across 21 analyst opinions.
Get $THC trade alerts by text
We text you when insiders, Congress or big funds trade $THC. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Tenet Healthcare Corporation alert may contain errors. Disclosures
Lone Pine Capital Increases Tenet Healthcare Position
Lone Pine Capital boosted its holdings in Tenet Healthcare Corporation (NYSE:THC) during the quarter ended May 15, 2026, according to a recent Form 13F filing with the U.S. Securities and Exchange Commission. The fund raised its stake by 26.4%, purchasing an additional 471,391 shares to bring its total ownership to 2,258,717 shares. Based on the reporting period, the position carried an estimated value of roughly $394.5 million. As 13F filings are backward-looking and reflect holdings at the close of the quarter, the data may not represent the investor's current position today.
Inside the Tenet Healthcare Stock Position
The fund's increased investment moves the prior share count of 1,787,326 up to 2,258,717 shares. This change reflects continued interest from the fund in the medical care facilities operator. Because 13F reports do not capture intraday trading or post-quarter adjustments, this filing serves as a quarterly snapshot of institutional positioning rather than an active real-time trade alert.
Tenet Healthcare Stock Context
Shares of Tenet Healthcare trade at $174.66, resting within a 52-week range of $157.58 to $283.05. The stock's P/E ratio sits at 10.1, with a forward P/E ratio of 12.4. It currently trades below its 50-day moving average of $250.51 and below its 200-day moving average of $211.09. The company features a market capitalization of roughly $21.0 billion, a current ratio of 1.41, and a debt-to-equity ratio of 152.28.
Recent Earnings Performance
For its recent financial reporting, Tenet Healthcare posted earnings per share of $25.86 on revenue of $21.8 billion, accompanied by a net margin of 10.3% and a return on equity of 37.3%. Revenue grew at a rate of 6.8% over the period. The company's next earnings report is scheduled for October 27, 2026.
Analysts Set New Price Targets
Wall Street analysts hold a positive view on the company, supported by a strong buy recommendation key across 21 analyst opinions and a mean price target of $285.57. Recent research notes show active coverage adjustments from major firms. On October 16, 2026, Guggenheim maintained its Buy rating with a $307.00 price target. Earlier, BMO Capital initiated coverage on September 23, 2026, with a Market Perform rating and a $265.00 price target, while Leerink Partners maintained an Outperform rating at $309.00 on September 18, 2026.
Overview of Tenet Healthcare Operations
Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States through its hospital operations and ambulatory care segments. The enterprise runs general hospitals offering acute care, surgical robotics, and diagnostic services, alongside ambulatory surgery centers and specialized clinics. Founded in 1967, the company is headquartered in Dallas, Texas, and employs approximately 77,000 people.
Looking Ahead After the Filing
Investors tracking Lone Pine Capital will look to future quarterly disclosures to see whether the fund maintains or adjusts its expanded healthcare holding. The upcoming earnings release on October 27, 2026, will provide fresh fundamental data on the company's hospital operations and ambulatory care segments. Market participants should note that 13F filings provide historical data and do not reflect ongoing portfolio changes.
Source: Lone Pine Capital's 13F filing on $THC (May 15, 2026). 13F filings show holdings as of the end of the reporting quarter and may not reflect the fund's current position. Find the original filing: Lone Pine Capital 13F filings on SEC EDGAR. Written by software, not financial advice. How we make alerts
